Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva ® (obinutuzumab) in adults with systemic lupus ...
In 2025, something unexpected happened. The programming language most notorious for its difficulty became the go-to choice ...
Ahead of International Women’s Day, new claims data from Healix Health highlights significant gender differences in health conditions and claims patterns. For ...
A Chrome extension named "QuickLens - Search Screen with Google Lens" has been removed from the Chrome Web Store after it was ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of ...
Merchants must prioritize total browser-side visibility and ensure client-side security across all web pages, not just the ...
Jodie Gallagher, Head of UK IFA Products at FE fundinfo, looks at how AI is being used to strengthen the operational backbone ...
Louder for the people in the back ...
The upstate New York firm makes precision components for data centers and semiconductor plants. It's bringing 230 jobs to the ...
A weakness in the configuration of OAuth credentials opens up a stored XSS vulnerability in the n8n automation platform, ...
“We will never know the depths of the harm happening inside detention centers.” ...
This high-severity Chrome Gemini vulnerability lets malicious extensions spy on your PC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results